2022 International Congress Archives - Page 79 of 153

Initial Postmarketing Real World Experience with directSTIM™ DBS System: A Case Series

W. Polanski, S. Sobottka, V. Coenen, A. Frank, B. Falkenburger (Dresden, Germany)
Insights from skin biopsies: α-synuclein real-time quaking-induced conversion (RT-QuIC) in patients with Parkinson’s disease and multiple system atrophy

C. Panzer, J. Volkmann, C. Sommer, K. Doppler, A. Kuzkina (Würzburg, Germany)
Intensive Multimodal Rehabilitation Intervention for Moderately Advanced Parkinson’s Disease

P. Moondra, A. Di Rocco, L. Rubin, C. Claro, A. Persaud, M. Mccrossin, A. Hernandez, D. Barreto, K. Schlosser, E. Stack, P. Fischetti, J. Yu, D. Green, L. Ptarcinski, K. Greco, G. Fequiere, C. Francavilla, B. Rubin, M. Tursi, J. Colton (Manhasset, USA)
Intermediate cardiac denervation in early Parkinson’s disease

S-W. Yoo, J-S. Kim (Seoul, Republic of Korea)
Intermuscular coherence as a biomarker of subthalamic nucleus deep brain stimulation efficacy in Parkinson’s disease

S. Lagerweij, J. van Zijl, T. van Laar, D. Oterdoom, J. van Dijk, M. Tijssen, J. Elting (Groningen, Netherlands)
Internal globus pallidus deep brain stimulation in ACTB-related deafness-dystonia

D. Macias-Garcia, S. Jesús, A. Adarmes-Gomez, L. Muñoz-Delgado, F. Carrillo, P. Mir (Seville, Spain)
International Telemedicine during COVID-19 Pandemic in an Academic Movement Disorder Clinic

N. Beltre, I. Haq, C. Luca, J. Margolesky, H. Paul, C. Singer, D. Shpiner (Miami, USA)
Interventions to Improve Gait in Parkinson’s Disease: A Systematic Review of Randomised Controlled Trials and Network Meta-Analysis

V. Hvingelby, A. Glud, JC. Sørensen, Y. Tai, AS. Andersen, VE. Johnsen, E. Moro, N. Pavese (Aarhus N, Denmark)
Intestinal microbial dysbiosis promotes prebiotic-reversible inflammation in Parkinson’s disease

R. Manfready, D. Hall, C. Goetz, A. Keshavarzian (Chicago, USA)
Intrafamilial phenotypic variability of spastic paraplegia type 7: A Case Report

D. Shah-Zamora, M. Rosenbaum (Chicago, USA)